|

Siplizumab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Elizabeth C. Verna1

Indications

  • Autoimmune Liver Disease1
  • Liver Transplant Disorder1
  • Liver Disease1
  • Autoimmune Hepatitis1
  • Cirrhosis, Liver1

New York, New York1 trial

A Study of SIPLIZUMAB in AILD and LT Patients

Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.